Friday, February 1, 2013

• Stocks Hold Near Session Highs; CommVault, Celgene Gainat Investor's Business Daily (Fri, Feb 1)
• Stocks Hold Positive Attitude; Carbo Ceramics, Perrigo Climbingat Investor's Business Daily (Fri, Feb 1)
• Celgene Stock Hits New 52-Week High (CELG)at TheStreet (Fri, Feb 1)

Thursday, January 31, 2013

• Duchenne Muscular Dystrophy Drug Could Unlock Huge Potential For This Pharmaceuticalat Motley Fool (Thu, Jan 31)
• Pluristem Moves to New FacilityZacks (Thu, Jan 31)
• 5 High-Profile Drugs Expect FDA Decisions in Februaryat Minyanville (Thu, Jan 31)

Wednesday, January 30, 2013

• 5 Rules For Speculating In Biotechat Seeking Alpha (Wed, Jan 30)
• 5 Stocks Pushing The Health Care Sector Lowerat TheStreet (Wed, Jan 30)
• IBD 50: Michael Kors, ARM Lead Top 5 Big-Cap Stocksat Investor's Business Daily (Wed, Jan 30)

Tuesday, January 29, 2013

• Acceleron begins Phase 2 trial of anemia treatment, earns $10M paymentat bizjournals.com (Tue, Jan 29)
• Prognosis Positive: Medical Growth Stocks to Watchat Motley Fool (Tue, Jan 29)

Monday, January 28, 2013

• Foolish Preview: Eli Lilly Earningsat Motley Fool (Mon, Jan 28)
• How Will More Earnings Affect The Market?at Seeking Alpha (Mon, Jan 28)
• Cancer Researcher-Turned-Billionaire Starts New Companyat Bloomberg (Mon, Jan 28)
• Buy, Sell, or Hold: Peregrine Pharmaceuticalsat Motley Fool (Mon, Jan 28)
• The Zacks Analyst Blog Highlights: Amgen, Celgene, Gilead Sciences, Vertex Pharmaceuticals and Nasdaq Biotechnology Index ETFZacks (Mon, Jan 28)

Sunday, January 27, 2013

• Will Threshold's MAESTRO Hit the Right Note?at Motley Fool (Sun, Jan 27)
• Why Celgene Still Looks Cheapat Motley Fool (Sun, Jan 27)
• 5 Stocks Billionaire Ken Fisher Dumped Last Quarterat Motley Fool (Sun, Jan 27)
• Celgene 2017 Guidance: 2 Times 2013 Revenueat Seeking Alpha (Sun, Jan 27)

Saturday, January 26, 2013

• This Week in Biotech: Part 1at Motley Fool (Sat, Jan 26)
• Bristol-Myers Squibb and 3 Top Pharma Stocks with Earnings Investors Must Seeat Wall St. Cheat Sheet (Sat, Jan 26)

Friday, January 25, 2013

• It's All Relative for This Biotech Underperformerat Motley Fool (Fri, Jan 25)
• Celgene Corporation (CELG): Today's Featured Health Care Winnerat TheStreet (Fri, Jan 25)
• Stephen Brozak: Changing The Way Money Is Made And Diseases Are Curedat Seeking Alpha (Fri, Jan 25)

Add CELG News to My Yahoo!